This composite educational graphic presents microangiographic imaging and quantitative data regarding Hypoxic Pulmonary Vasoconstriction (HPV). Panel A displays a matrix of selective pulmonary microangiograms comparing N-rats (normoxic-raised) and IH-rats (intermittent hypoxia-raised) under various conditions: normoxia, acute hypoxia, and hypoxia following pretreatment with beta-blockers Atenolol (beta-1 selective) or Nadolol (non-selective beta-1/beta-2). In N-rats, acute hypoxia induces visible narrowing of small pulmonary arteries (indicated by black arrows). This response is blunted in IH-rats but significantly restored after Nadolol administration, suggesting beta-2 adrenergic receptor involvement in IH-induced HPV attenuation. Panels B, C, and D provide quantitative line graphs plotting '% change in diameter' against 'vessel diameter (micrometers)' for these cohorts. The data highlights that HPV is most pronounced in vessels measuring 200–300 µm. The graphs statistically confirm that while Atenolol does not correct the blunted HPV in IH-rats, Nadolol returns the vasoconstrictive response to levels comparable to N-rats. This visual illustrates the pathophysiology of pulmonary vascular reactivity and the role of peripheral beta-adrenergic receptors in chronic hypoxia adaptations.

This pathophysiology diagram illustrates the immune-inflammatory landscape of Hypoxic Pulmonary Hypertension (HPH), divided into three compartments: blood vessel, lung parenchyma, and pulmonary vasculature. The left section shows the transendothelial migration of immune cells, including monocytes, T cells, and neutrophils, from the circulation into the lung tissue. The central 'Lung parenchyma' section details the differentiation and signaling pathways of resident and recruited cells, such as M1/M2 macrophages (modulated by HIF-1α, NF-κB, and PPARγ), dendritic cells (cDC, pDC), γδT cells, Th17 cells, and regulatory T/B cells (Treg, Breg). Key cytokines and chemokines (CCL2, CCL5, CXCL9, CXCL10, IL-6, IL-17, IL-10) are mapped to specific cellular interactions. The right section focuses on the 'Pulmonary vasculature,' detailing structural remodeling in HPH across three vessel layers: the intima (endothelial cell hyperproliferation, EndMT, vasoconstriction), the media (smooth muscle cell hyperproliferation, arteriolar muscularization), and the adventitia (extracellular matrix deposition, fibrosis). The diagram emphasizes the cross-talk between inflammatory mediators (like TNF-α, IL-1β, ROS, and NETs) and metabolic reprogramming in the progression of pulmonary vascular lesions.

Educational medical infographic illustrating the setup and pathophysiology of Hypoxic Simulation Testing using Transthoracic Echocardiography (TTE). The clinical setup shows a patient in a semi-recumbent position on a hospital bed, breathing a low-oxygen gas mixture delivered via a face mask from a hypoxic generator. A bedside echocardiography machine is actively monitoring cardiac function. The visual includes two comparative four-chamber view ultrasound frames: 'Baseline' (normal cardiac morphology) and 'Peak' (showing changes during maximum hypoxia). A physiological inset diagram explains the underlying mechanism: inhalation of the hypoxic mixture triggers pulmonary vasoconstriction and increased Pulmonary Vascular Resistance (PVR), which subsequently leads to elevated Right Ventricular (RV) pressure. This illustration is used to teach diagnostic approaches for evaluating pulmonary hypertension susceptibility and right-to-left shunting (e.g., patent foramen ovale) under physiological stress.